German neuroblastoma mass screening study at 12 months of age: statistical aspects and preliminary results
- 1 November 1998
- journal article
- research article
- Published by Wiley in Medical and Pediatric Oncology
- Vol. 31 (5) , 435-441
- https://doi.org/10.1002/(sici)1096-911x(199811)31:5<435::aid-mpo9>3.0.co;2-y
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Mass screening for neuroblastoma and mortality in birth cohortsInternational Journal of Cancer, 1997
- A population-based study of the usefulness of screening for neuroblastomaThe Lancet, 1996
- Where should neuroblastoma mass screening go?The Lancet, 1996
- A 5-year (1990–1994) neuroblastoma screening feasibility study in France. Methodology and preliminary observationsEarly Human Development, 1996
- Screening for neuroblastomaThe Lancet, 1994
- A Pilot Study of Screening for Neuroblastoma in the North of EnglandJournal of Pediatric Hematology/Oncology, 1992
- Disseminated neuroblastoma (stage IV and IV-S) in the first year of life. Outcome related to age and stageCancer, 1992
- “Decrease in childhood neuroblastoma death in Japan,” Hanawa et al. (1990)Medical and Pediatric Oncology, 1992
- Mass screening in Japan increased the detection of infants with neuroblastoma without a decrease in cases in older childrenThe Journal of Pediatrics, 1991
- Decrease in childhood neuroblastoma death in JapanMedical and Pediatric Oncology, 1990